Global pharmaceutical company Allergan has announced plans to invest more than €42 million (over £36 million) in an expansion.
American biopharmaceutical company AbbVie has agreed to buy global pharmaceutical company Allergan in a $63 billion cash and stock deal.
Aesthetic practitioner and founder of VIVA Skin Clinics, Dr Rupert Critchley, has launched a new training scheme for aesthetic injectors.
Tessa Hilado, executive vice president and chief financial officer has retired from her post at global pharmaceutical company Allergan.
Practitioners, clinics, manufacturers and distributors in the aesthetics specialty will again have the opportunity to win a prestigious Aesthetics Award, with applications opening on May 2.
Spanish pharmaceutical company Almirall has entered into an agreement to acquire Allergan’s US medical dermatology unit portfolio, consisting of five brands for acne and dermatoses treatment.
Global pharmaceutical company Galderma has appointed Kendrick PR and Mantlepiece PR as its new UK representatives.
A survey has suggested that 47% of adults are bothered by the appearance of the area under their chin.
Global pharmaceutical company Allergan has confirmed that it has received Food and Drug Administration (FDA) approval to market JUVÉDERM VOLLURE XC for the correction of moderate to severe facial wrinkles and folds in the US.
Aesthetic training provider Medical Aesthetic Training Academy (MATA) has announced the launch of its business mentorship scheme.